Search results (3180)
« Back to PublicationsThe CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19.
Kazungu Y. et al, (2026), Virulence, 17
Developing a global framework to assess a country's readiness and resilience to introduce a new vaccine or improve uptake of an underutilized vaccine.
Monk V. et al, (2026), Expert Rev Vaccines, 25
Cellular immunity to Streptococcus pneumoniae: implications for vaccine-mediated prevention.
VanSeggelen H. et al, (2026), Expert Rev Vaccines, 25
Differential ChAdOx1 and ChAdOx2 transduction efficiency and receptor specificity in human and mouse B cell lines in vitro.
Nazki S. et al, (2026), Virology, 624
Parental motivations, facilitators, and barriers to participating in a pediatric vaccine trial in Kathmandu, Nepal: A qualitative study.
Firth C. et al, (2026), Hum Vaccin Immunother, 22
What is unhealthy about public health? Vaccination, evidence and the politics of uncertainty
Mezza M. and Vanderslott S., (2026), Humanities and Social Sciences Communications, 13
Asymmetric cell division is predictive of human T cell vaccine responses.
Luo L. et al, (2026), Sci Adv, 12
Century of childhood immunisation through the lens of Archives of Disease in Childhood.
Charlesworth JEG. et al, (2026), Arch Dis Child
Streptococcus pneumoniae genomic stability during human experimental colonization and vaccination.
Stanley S. et al, (2026), J Infect Dis
Science, not politics: the ESCMID view on protecting populations against measles, mumps and rubella.
ESCMID Executive Committee . and ESCMID Vaccines Subcommittee ., (2026), Clin Microbiol Infect
Experimental pneumococcal carriage reveals humoral correlates of susceptibility in virally suppressed adults with HIV.
Doherty K. et al, (2026), J Infect Dis